Creso Pharma Limited created partnership with National University of Colombia in Bogota. Creso will leverage an expert medical network to support the development and validation of its therapeutic and nutraceutical products. Creso is licensed to complete research and development, cultivate, manufacture, distribute and export. Creso's nursery is in the final stages of genetic registration and Creso is awaiting final word on quota issued by the authorities. Colombia represents a significant strategic foothold for Creso as it will serve as a low cost source of psycho-active and non psycho-active medicinal cannabis for South America and Europe.